Stay updated on Vemurafenib & Cobimetinib in BRAF V600E Craniopharyngioma Clinical Trial

Sign up to get notified when there's something new on the Vemurafenib & Cobimetinib in BRAF V600E Craniopharyngioma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Vemurafenib & Cobimetinib in BRAF V600E Craniopharyngioma Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added and the government funding status notice about a lapse in funding was removed; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-02-11T09:18:05.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    A government funding/status notice was added indicating the NIH Clinical Center is open and updates regarding operating status. The page was updated to Revision: v3.4.1, replacing the previous v3.4.0 revision.
    Difference
    0.2%
    Check dated 2026-02-04T05:23:21.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    Added a glossary toggle and updated the page revision to v3.4.0. Capitalization of terms related to QC criteria and FEAR Act data has been standardized.
    Difference
    0.1%
    Check dated 2026-01-28T03:44:50.000Z thumbnail image
  6. Check
    44 days ago
    Change Detected
    Summary
    Page revision updated from v3.3.3 to v3.3.4.
    Difference
    0.0%
    Check dated 2026-01-14T02:25:23.000Z thumbnail image
  7. Check
    65 days ago
    Change Detected
    Summary
    Added a Locations section listing participating sites by state and updated to Revision: v3.3.3; removed the prior state location entries and the HHS Vulnerability Disclosure link.
    Difference
    1%
    Check dated 2025-12-23T17:35:10.000Z thumbnail image
  8. Check
    94 days ago
    Change Detected
    Summary
    Publications section updated to clarify entries are automatically filled from PubMed and to reflect revision v3.3.2.
    Difference
    0.1%
    Check dated 2025-11-24T21:06:48.000Z thumbnail image

Stay in the know with updates to Vemurafenib & Cobimetinib in BRAF V600E Craniopharyngioma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Vemurafenib & Cobimetinib in BRAF V600E Craniopharyngioma Clinical Trial page.